Funding Rounds
Antabio

Antabio Series B (2023, $26M)

Antabio

Developer of MEM-ANT3310, a next generation antibacterial combination.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $26.96M

Raised Date: 2023-12-01

Investors